Camp4 Therapeutics CAMP Income Statement (2023-2026)

NASDAQ CAMP
$4.20 -0.13 (-3.00%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Camp4 Therapeutics Quarterly Income Statement

Periods 13 quarters
Latest Sep 2026

Camp4 Therapeutics reported revenue of $1.90M and net income of -$28.96M for the quarter ended Sep 2026, up 138.9% year over year. This income statement covers 13 quarters of results from Sep 2023 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue 0.35M0.65M0.86M1.50M0.80M0.35M1.29M1.78M1.90M
Operating items
Research & DevelopmentR&D 9.82M10.66M9.74M9.39M9.70M10.00M10.15M10.34M9.85M7.86M10.16M10.82M11.43M
Selling, General & AdministrativeSG&A 2.87M2.82M3.14M3.27M3.81M4.69M3.81M4.18M4.60M4.77M4.21M4.34M4.49M
Other Operating ExpensesOther Opex 0.49M
Operating ExpensesOpex 12.69M13.48M12.88M12.66M13.52M14.69M13.96M14.53M14.45M13.12M14.37M15.16M15.93M
Operating IncomeOp. Inc -12.34M-13.48M-12.88M-12.66M-13.52M-14.03M-13.10M-13.03M-13.65M-12.78M-13.07M-13.38M-14.03M
Non-operating items
Interest & Investment IncomeInt & Inv Inc 0.69M0.57M0.40M0.23M0.09M0.61M0.59M0.45M0.42M0.71M0.91M0.81M0.98M
Other Non Operating IncomeOther Non Op Inc. 0.05M0.08M0.03M-0.15M-0.06M0.21M0.08M-0.01M-1.87M-27.83M-6.17M-20.96M-15.91M
Non Operating IncomeNon Op. Inc. 0.64M0.49M0.42M0.09M0.03M0.76M0.67M0.44M-1.45M-27.51M-5.26M-20.15M-14.93M
Net income details
EBIT -12.34M-13.48M-12.88M-12.66M-13.52M-14.03M-13.10M-13.03M-13.65M-12.78M-13.07M-13.38M-14.03M
EBT -11.65M-12.91M-12.48M-12.43M-13.42M-13.42M-12.51M-12.58M-13.23M-12.07M-12.16M-12.57M-13.05M
Income After Tax -11.65M-12.91M-12.48M-12.43M-13.42M-13.42M-12.51M-12.58M-13.23M-12.07M-12.16M-12.57M-13.05M
Income from Continuing OperationsIncome (Continuing) -11.65M-12.91M-12.48M-12.43M-13.42M-13.42M-12.51M-12.58M-13.23M-12.07M-12.16M-12.57M-13.05M
Consolidated Net IncomeConsol Net Inc. -11.70M-12.99M-12.45M-12.58M-13.48M-13.28M-12.43M-12.59M-15.10M-40.28M-18.33M-33.53M-28.96M
Income towards Parent CompanyParent Net Inc -11.70M-12.99M-12.46M-12.57M-13.48M-13.28M-12.43M-12.59M-15.10M-40.28M-18.33M-33.53M-28.96M
Net Income towards Common StockholdersNet Income -11.70M-12.99M-12.45M-12.58M-13.48M-13.28M-12.43M-12.59M-15.10M-40.28M-18.33M-33.53M-28.96M
Additional items
EPS (Basic) -29.21-32.89-26.57-26.00-24.19-2.83-0.62-0.62-0.55-1.33-0.32-0.58-0.37
EPS (Diluted) -29.21-32.89-26.57-26.00-24.19-2.83-0.62-0.62-0.55-1.33-0.32-0.58-0.37
Shares Outstanding 0.40M0.39M0.47M0.48M0.56M4.69M20.15M20.16M27.27M30.38M57.92M57.93M78.95M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.40M0.39M0.47M0.48M0.56M4.69M20.15M20.16M27.27M30.38M57.92M57.93M78.95M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.40M0.39M0.47M0.48M0.56M4.69M20.16M20.16M27.27M30.38M51.93M51.93M78.95M
EBITDA -13.04M-12.44M-12.24M-13.10M-13.62M-12.68M-12.60M-13.24M-12.40M-12.55M-12.87M-13.51M

Camp4 Therapeutics Income Statement API

Pull Camp4 Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CAMP&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY